post-COVID syndrome (long COVID)
Conditions
Brief summary
Quantitative measures of [18F]Flutemetamol binding throughout the body of participants, expressed in parameters such as volume of distribution (VT) or non displaceable binding potential (BPND) (depending on the most suitable kinetic model per region or tissue of interest (ROI)).
Detailed description
Amyloid-containing microclot load (size and quantity) in blood., Questionnaire scores on presence and severity of (post-COVID) symptoms, MRI-derived parameters on brain structure and function.
Interventions
Sponsors
Amsterdam UMC Stichting
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantitative measures of [18F]Flutemetamol binding throughout the body of participants, expressed in parameters such as volume of distribution (VT) or non displaceable binding potential (BPND) (depending on the most suitable kinetic model per region or tissue of interest (ROI)). | — |
Secondary
| Measure | Time frame |
|---|---|
| Amyloid-containing microclot load (size and quantity) in blood., Questionnaire scores on presence and severity of (post-COVID) symptoms, MRI-derived parameters on brain structure and function. | — |
Outcome results
None listed